We are live on ! Find out more
MGNX icon

MacroGenics

173 hedge funds and large institutions have $1.8B invested in MacroGenics in 2021 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 62 increasing their positions, 47 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more funds holding in top 10

Funds holding in top 10: 27 (+5)

193% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 14

89% more call options, than puts

Call options by funds: $24.2M | Put options by funds: $12.8M

46% more capital invested

Capital invested by funds: $1.23B → $1.8B (+$571M)

32% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 47

18% more funds holding

Funds holding: 147173 (+26)

5.15% more ownership

Funds ownership: 95.7%100.85% (+5.1%)

Holders
173
Holders Change
+26
Holders Change %
+17.69%
% of All Funds
3.04%
Holding in Top 10
7
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+250%
% of All Funds
0.12%
New
41
Increased
62
Reduced
47
Closed
14
Calls
$24.2M
Puts
$12.8M
Net Calls
+$11.4M
Net Calls Change
+$13.3M

MGNX Hedge Fund Activity: Q1 2021 in Review

173 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q1 2021, worth a combined $1.8B — up 46% from $1.23B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new MGNX positions and 14 closed out — a net gain of 27 holders — while 62 added to existing stakes and 47 trimmed.

The largest buyer was Victory Capital Management, adding an estimated $28.6M. The largest seller was Invesco, cutting an estimated $72.7M.

  • 173 institutional investors held MacroGenics (MGNX) as of Q1 2021, up from 147 in Q4 2020.
  • Funds reported $1.8B of MacroGenics stock for Q1 2021, up 46% quarter-over-quarter.
  • 41 funds opened new MacroGenics positions in Q1 2021 and 14 closed out, a net change of +27 holders.
  • The largest MacroGenics buyer in Q1 2021 was Victory Capital Management, an estimated $28.6M added.
  • The largest MacroGenics seller in Q1 2021 was Invesco, an estimated $72.7M sold.

Based on aggregated 13F filings for Q1 2021.